<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00102284</url>
  </required_header>
  <id_info>
    <org_study_id>KS-NEUROMOD_01, Stage Ia</org_study_id>
    <secondary_id>IZKF Muenster: Kne3/074/04</secondary_id>
    <nct_id>NCT00102284</nct_id>
  </id_info>
  <brief_title>Neuromodulation and Language Acquisition (Project Stage Ia)</brief_title>
  <official_title>Improved Language Acquisition Through Neuromodulation, Project Stage Ia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Muenster</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether levodopa, pergolid, rivastigmine, or
      modafinil are effective in boosting semantic language acquisition in healthy subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our prior work shows that d-amphetamine and the dopamine precursor levodopa markedly improve
      word learning success in healthy subjects. In this randomized, placebo-controlled,
      double-blind clinical trial, we probe whether a mixed d1/d2 dopamine agonist (pergolid) or
      cholinergic neuromodulation (rivastigmine) or a general centrally arousing substance
      (modafinil) will yield a learning enhancement comparable to using levodopa in healthy
      subjects.

      Our results show that the dopamine agonist pergolide impaired learning in healthy subjects
      compared to placebo, whereas cholinergic neuromodulation had no effect.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>March 2004</start_date>
  <completion_date>April 2005</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Boost in language learning success through neuromodulation</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stability of language learning success</measure>
  </secondary_outcome>
  <enrollment>100</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levodopa</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>rivastigmine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pergolid</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>modafinil</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects

          -  20-35 years old

          -  Right handedness

          -  Left language dominance (as assessed by functional transcranial Doppler
             ultrasonography [fTCD])

        Exclusion Criteria:

          -  Neurological/psychiatric/metabolic/cardiac disorders

          -  Asthma

          -  Known allergic reactions to one of the experimental drugs

          -  Other drugs affecting the central nervous system

          -  Leisure drug ingestion during the past 4 weeks (urine test)

          -  Smoking cessation during the past 2 weeks

          -  &gt; 6 cups of coffee or energy drinks per day

          -  &gt; 10 cigarettes per day

          -  &gt; 50 grams of alcohol per day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caterina Breitenstein, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Dept. of Neurology, University Hospital Muenster</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefan Knecht, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Neurology, University Hospital Muenster</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Neurology, University Hospital Muenster</name>
      <address>
        <city>Muenster</city>
        <state>Nordrhein-Westfalen</state>
        <zip>48129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://neurologie.uni-muenster.de/cms/front_content.php?client=1&amp;lang=1&amp;idcat=37&amp;idart=117&amp;suchwort=Caterina+Breitenstein</url>
    <description>Homepage of Dr. Breitenstein</description>
  </link>
  <reference>
    <citation>Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Flöel A, Zwitserlood P, Ringelstein EB. Levodopa: faster and better word learning in normal humans. Ann Neurol. 2004 Jul;56(1):20-6.</citation>
    <PMID>15236398</PMID>
  </reference>
  <reference>
    <citation>Breitenstein C, Wailke S, Bushuven S, Kamping S, Zwitserlood P, Ringelstein EB, Knecht S. D-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. Neuropsychopharmacology. 2004 Sep;29(9):1704-14.</citation>
    <PMID>15114342</PMID>
  </reference>
  <reference>
    <citation>Breitenstein C, Flöel A, Korsukewitz C, Wailke S, Bushuven S, Knecht S. A shift of paradigm: from noradrenergic to dopaminergic modulation of learning? J Neurol Sci. 2006 Oct 25;248(1-2):42-7. Epub 2006 Jul 11.</citation>
    <PMID>16815467</PMID>
  </reference>
  <reference>
    <citation>Korsukewitz C, Breitenstein C, Schomacher M, Knecht S. [Present status and future possibilities of adjuvant pharmacotherapy for aphasia]. Nervenarzt. 2006 Apr;77(4):403-15. Review. German.</citation>
    <PMID>16273340</PMID>
  </reference>
  <results_reference>
    <citation>Breitenstein C, Korsukewitz C, Flöel A, Kretzschmar T, Diederich K, Knecht S. Tonic dopaminergic stimulation impairs associative learning in healthy subjects. Neuropsychopharmacology. 2006 Nov;31(11):2552-64. Epub 2006 Jul 26.</citation>
    <PMID>16880771</PMID>
  </results_reference>
  <verification_date>September 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2005</study_first_submitted>
  <study_first_submitted_qc>January 26, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2005</study_first_posted>
  <last_update_submitted>January 26, 2010</last_update_submitted>
  <last_update_submitted_qc>January 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2010</last_update_posted>
  <keyword>language acquisition</keyword>
  <keyword>plasticity</keyword>
  <keyword>stroke recovery</keyword>
  <keyword>associative learning</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levodopa</mesh_term>
    <mesh_term>Rivastigmine</mesh_term>
    <mesh_term>Modafinil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

